Zydus gets final approval for Acetylcysteine Injection from USFDA
Mumbai: Pharma Major, Zydus Cadila has received the final approval from the USFDA to market Acetylcysteine Injection (US RLD - Acetadote Injection), 6 g/30 mL (200 mg/mL).
It is an antidote for acetaminophen overdose indicated to prevent or lessen hepatic injury after ingestion of a potentially hepatotoxic quantity of acetaminophen, the company said in a filing with BSE.
It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.
In line with this, the group now has 211 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd